PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
01-Aug-2024 FDA Recognizes Fibromyalgia as a 'Serious Condition' And Fast-Tracks New Drug Candidate AccessWire
01-Aug-2024 Preclinical and Clinical Pharmacokinetic, Pharmacodynamic, and Safety Data of Targeted Oral Peptide JNJ-2113 Published in Scientific Reports AccessWire
01-Aug-2024 Bausch Health Announces Second Quarter 2024 Results AccessWire
01-Aug-2024 OMS360 Appoints Dr. Joshua Everts as Chief Clinical Officer AccessWire
01-Aug-2024 Thomas Pfaadt appointed as new Chief Financial Officer of Vita 34 AG Vita 34 AG
01-Aug-2024 Immunic, Inc. to Announce Financial Results for the Second Quarter Ended June 30, 2024, and Provide Corporate Update Immunic AG
01-Aug-2024 Moderna Reports Second Quarter 2024 Financial Results and Provides Business Updates AccessWire
01-Aug-2024 Zomedica to Report Second Quarter 2024 Financial Results and Provide Business Update on August 14 at 4:30 p.m. ET AccessWire
01-Aug-2024 "NanoViricides Broad Spectrum Technology Represents Potential Paradigm Shift In Viral Therapy"; "Novel Anti-Viral Could Boost a US$3 Billion Market" - Conclude Two Independent Research Reports on NanoViricides AccessWire
01-Aug-2024 Polaroid Therapeutics and SFM Limited Announce Strategic Partnership to Advance AMR Management Polaroid Therapeutics
01-Aug-2024 MindBio Therapeutics Appoints Haywood Securities to Conduct Strategic Investment Advisory AccessWire
01-Aug-2024 Transgene strengthens its balance sheet via equity conversion of current account advance from TSGH Transgene
01-Aug-2024 New number of shares and votes in Moberg Pharma AB (publ) Moberg Pharma
01-Aug-2024 Lundbeck and Takeda modify the collaboration agreement for Trintellix in the U.S H. Lundbeck A/S
01-Aug-2024 Eisai present clinical data for continuous treatment with lecanemab at The Alzheimer’s Association International Conference 2024 Eisai
01-Aug-2024 As blood stock shortage crisis continues, less than half of Brits know their blood type, says expert London Medical Laboratory
01-Aug-2024 Novo Holdings Invests in UK-Listed Oxford Nanopore Technologies Novo Holdings
01-Aug-2024 INDEPENDENT PARSORTIX STUDY HIGHLIGHTS BENEFITS OF COMBINED DNA ANALYSIS IN MELANOMA ANGLE plc
01-Aug-2024 GenesisCare UK Strengthens Board with Appointment of Three Non-Executive Directors GenesisCare UK
01-Aug-2024 Novo Holdings Invests in UK-Listed Oxford Nanopore Technologies Novo Holdings